Wireless patient monitoring firm BioTelemetry Inc. will acquire centralized cardiac testing services laboratory CardioCore Lab for $23.5 million under a definitive agreement announced Aug. 6. With the purchase, “we are truly becoming a full-service cardiac monitoring company,” said CardioNet CEO Joseph Capper. CardioNet, which makes the MCOT mobile cardiac outpatient telemetry system, noted that the deal “goes a long way in mitigating some of our revenue concentration and reimbursement risk.” CardioCore offers cardiac testing services to the pharmaceutical industry as part of clinical trials and operates out of facilities near Washington, D.C., San Francisco and London; the firm has annual sales of about $20 million. CardioNet says it expects the deal to close by Sept. 30.
HeartWare International Inc. is on track to have 30 U.S. sales reps in place “within the next month” in...